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Abstract
Background: Numerous studies have documented high rates of functional impairment among bipolar disorder
(BD) patients, even during phases of remission. However, the majority of the available instruments used to assess
functioning have focused on global measures of functional recovery rather than specific domains of psychosocial
functioning. In this context, the Functioning Assessment Short Test (FAST) is a brief instrument designed to assess
the main functioning problems experienced by psychiatric patients, particularly bipolar patients. It comprises 24
items that assess impairment or disability in six specific areas of functioning: autonomy, occupational functioning,
cognitive functioning, financial issues, interpersonal relationships and leisure time.
Methods: 101 patients with DSM-IV TR bipolar disorder and 61 healthy controls were assessed in the Bipolar
Disorder Program, Hospital Clinic of Barcelona. The psychometric properties of FAST (feasibility, internal
consistency, concurrent validity, discriminant validity (euthymic vs acute patients), factorial analyses, and test-
retest reliability) were analysed.
Results: The internal consistency obtained was very high with a Cronbach's alpha of 0.909. A highly significant
negative correlation with GAF was obtained (r = -0.903; p < 0.001) pointing to a reasonable degree of concurrent
validity. Test-retest reliability analysis showed a strong correlation between the two measures carried out one
week apart (ICC = 0.98; p < 0.001). The total FAST scores were lower in euthymic (18.55 ± 13.19; F = 35.43; p
< 0.001) patients, as compared with manic (40.44 ± 9.15) and depressive patients (43.21 ± 13.34).
Conclusion: The FAST showed strong psychometrics properties and was able to detect differences between
euthymic and acute BD patients. In addition, it is a short (6 minutes) simple interview-administered instrument,
which is easy to apply and requires only a short period of time for its application.
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Background
Kraepelin in 1921 [1] noted that manic or depressive epi-
sodes were periodic in nature, and typically were followed
by a return to what was then considered normal function-
ing. In contrast to early studies, recent studies do not
describe such a favourable outcome in patients with bipo-
lar disorder [2-5]. Tohen et al. (2000) [6] showed that
although 97.5% of bipolar patients achieved syndromal
recovery 24 months after admission, only 37.6% achieved
functional recovery. Strakowski et al. (2000) [7], in a 8-
month follow-up study, reported that nearly all of the
remitted patients exhibited persistent impairment in at
least one area of functioning and less than half achieved a
good functional outcome in three of the four areas of
functioning studied.
The concept of functioning is complex and involves many
different domains including the capacity to work, capacity
to live independently, capacity for recreation, capacity for
romantic life, and capacity to study [4,6,8]. Researchers
traditionally measure one or two elements of functioning
and typically fail to take into account all the other ele-
ments necessary for optimal functioning. The measures
used to assess functional impairment in BD varied greatly
across studies, only a few instruments were used by more
than two researchers [3,9,10]. Among multidimensional
scales assessing functioning, the Global Assessment of
Functioning scale (GAF) is the most commonly used, but
the original GAF instructions call for rating symptoms as
well as functioning [11-13]. Beyond these scales, the
Social Adjustment Scale (SAS), the Life Functioning Ques-
tionnaire (LFQ), the Short Form-36 (SF-36) and the
WHO-DAS are also used, but none were specific instru-
ments developed to assess specific areas of functional
impairment in bipolar disorder and required a longer
time for its administration.
Future studies should be sensitive to the need for meas-
ures to evaluate the impact of illness factors on each
domain of functioning [3] and the development of instru-
ments that capture the specific issues related to severe
mental illness and particularly BD are required [14]. The
FAST (Functioning Assessment Short Test) was developed
for the clinical evaluation of functional impairment pre-
sented by patients suffering from mental disorders includ-
ing bipolar disorder. It is a simple instrument, easy to
apply and that requires a very short time to be adminis-
tered. The 24 items of the scale are divided among 6 spe-
cific areas of functioning: autonomy, occupational
functioning, cognitive functioning, financial issues, inter-
personal relationships and leisure time. Taking into con-
sideration the opinion of experts the performance of
previous scales and the literature, the aforementioned
items were identified as the main problems experienced
by the mentally ill, including bipolar patients [7,15-17].
The purpose of the present study was to validate the Span-
ish version of the FAST for its use as an instrument to
assess functional impairment in subjects with bipolar dis-
order.
Methods
1. Subjects
The study was conducted in the Bipolar Disorder Pro-
gram, Hospital Clinic of Barcelona, Spain. One hundred
and one bipolar patients were selected according to the
Structured Clinical Interview for the DSM-IV TR criteria
[11].
The study was approved by the Hospital Clinic of Barce-
lona Ethics Committee and was carried out in compliance
with the Helsinki Declaration of 1975 (the Evaluation,
Support and Prevention Unit).
2. Variables
After informing the patients and obtaining their consent,
the investigator recorded their socio-demographic and
clinical variables and administered the Spanish version of
the Young Mania Rating Scale (YMRS) [18], Spanish ver-
sion of the 17-item Hamilton Depression Rating Scale
(HDRS-17) [19] and the Global Assessment Functioning
(GAF) [20] to confirm the stability of the patient's condi-
tion and overall functioning. They also recorded all the
medication prescribed to the patients for this visit. Finally,
the investigator administered the FAST. Interviewers
administering the FAST and the GAF were blinded to each
other.
Sixty one control subjects were screened using the SCID
(DSM-IV TR) to exclude current or lifetime psychiatric dis-
orders. Controls had no first-degree relatives with bipolar
disorder or other psychiatric disorders. The healthy com-
parison group was recruited from the general population
within the catchment area of the Hospital Clinic, Barce-
lona, and gave written informed consent to participate in
this study.
3. FAST
3.1. Development
The FAST was developed by the Bipolar Disorder Program,
Barcelona, Spain, to assess functional impairment focus-
ing on the main problems experienced by the mentally ill,
including bipolar patients. The initial version of the FAST
included 56 items divided into 10 specific areas, such as
autonomy, work functioning, cognitive functioning,
finances, insight, social/marital life, acceptance/knowl-
edge disorder, strategies to cope with symptoms, use of
medication, and self-fulfilment. This version was studied
in a pilot study with ten bipolar patients and ten healthy
controls. After preliminary analysis, the scale was dis-
cussed in a meeting with experts from Spain, Brazil andClinical Practice and Epidemiology in Mental Health 2007, 3:5 http://www.cpementalhealth.com/content/3/1/5
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England and several changes were made and some items
were rejected. Then, the final version of the FAST was
designed.
3.2. Description
The FAST is an interviewer-administered instrument
which is designed to be used by a trained clinician; the
studied time frame refers to the last 15 days before assess-
ment. It is a quite simple instrument, easy to apply and
which only requires a short time to apply (see additional
files 2 and 2). It comprises 24 items, which are divided
among 6 specific areas of functioning:
1) Autonomy refers to the capacity of the patient of doing
things alone and take his/her own decisions.
2) Occupational functioning refers to the capacity to
maintain a paid job, efficiency of performing tasks at
work, working in the field in which the patient was edu-
cated and earning according to the level of the employ-
ment position.
3) Cognitive functioning is related to the ability to con-
centrate, perform simple mental calculations, solve prob-
lems, learn new information and remember learned
information.
4) Financial issues involve the capacity of managing the
finances and spending in a balanced way.
5) Interpersonal relationships refer to relations with
friends, family, involvement in social activities, sexual
relations and the ability to defend ideas and opinions.
6) Leisure Time refers to the capacity of performing phys-
ical activities (sport, exercise) and the enjoyment of hob-
bies.
All of items are rated using a 4-point scale, 0 = no diffi-
culty, 1 = mild difficulty, 2 = moderate difficulty and 3 =
severe difficulty. The global score is obtained when the
scores of each item are added up. The higher the score, the
more serious the difficulties are, so FAST is actually meas-
uring disability.
4. Psychometrics
We analysed the feasibility, internal consistency, concur-
rent validity, validity as a discriminative measure to detect
difference between euthymic and acute patients, factorial
analyses and test-retest reliability of the FAST. Except for
test-retest reliability, the psychometric characteristics of
the FAST are derived from the first administration of the
questionnaire, including all the subjects who completed it
in the analysis.
4.1. Feasibility is described as the percentage of patients
who did not respond to the questionnaire in its entirety.
It also includes the time spent in completing the instru-
ment as a measure of how practical it may be for busy cli-
nicians and for its inclusion in clinical trials and other
studies.
4.2. Internal consistency reliability assesses the degree to
which questions on an instrument measure the same
underlying concept. The alpha internal consistency coeffi-
cient of reliability (Cronbach's Alpha) was used to exam-
ine the internal consistency of the FAST items in each
domain and total scale. The correlation between each
domain and the total scores was calculated.
4.3. Concurrent validity was studied considering GAF
instrument and the score obtained on the FAST applying
the Pearson correlation coefficient [21]. The GAF was cho-
sen as the scale to assess concurrent validity of the FAST
because it is probably the main instrument for assessing
functional outcome in mental disorders.
4.4. The optimal point for the FAST was determined by
means of ROC curves.
4.5. Test-retest reliability: Intra-class correlation coeffi-
cient was performed to assess test-retest reliability, 15 sub-
jects were identified who had remained stable for at least
one week, according to YMRS, HDRS-17 and GAF. These
15 subjects then participated in a Test-Retest reliability
assessment one week later.
4.6. Validity as a discriminative measure to detect differ-
ence between euthymic and acute patients: the partici-
pants were stratified by severity of symptoms in euthymia,
mania, and depression, as determined by a clinical assess-
ment based on DSM-IV TR. An ANOVA analysis was used
to evaluate whether the FAST total scores were sensitive to
the severity of symptoms.
4.7. An orthogonal factorial analysis by matrix rotation
was performed to describe the internal structure of each
domain of FAST.
5. Statistical analysis
Statistical analysis was performed using SPSS for Win-
dows – Version 12.0 (SPSS Inc., Chicago, IL, USa). Pear-
son's correlation coefficient was performed to examine
the correlation between FAST and GAF scores. Internal
consistency was analyzed using the Cronbach's alpha.
Total scores of FAST of three groups (euthymic, manic or
depressed) were compared using a one-way ANOVA.
When ANOVA comparing more than two groups showed
significant differences, the individual Tukey HSD test was
performed. Intra-class correlation coefficient was per-Clinical Practice and Epidemiology in Mental Health 2007, 3:5 http://www.cpementalhealth.com/content/3/1/5
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formed to assess the reliability between test and retest. The
rotation was performed using the Varimax method.
Results
Seventy one euthymic, fourteen depressive and sixteen
manic patients were enrolled to participate in the study.
The mean age of the patients was 45 years (SD: 13.66,
median 45.45, ranging from 22 to 82) and mean age of
the controls was 49 years (SD:17.66, median 49.16, rang-
ing from 22 to 81). 51.5% of patients and 57.4% of con-
trols were women. There were no significant differences
between the groups in demographic baseline assessment.
Table 1 describes the main socio-demographic and clini-
cal characteristics of the sample. in.
Among the 101 bipolar patients, mood stabilizing agents
were the most commonly prescribed agents (81.6%),
including lithium (59.2%), valproate (13.6%) and car-
bamazepine (9.7%); 12.6 % received lamotrigine; 63.1%
antipsychotics, 30.1% antidepressants and 48.5% anxio-
lytic-sedatives.
All items of the FAST were answered by 99% the patients
(n = 100) in every test session. The mean time spent in
completing the instrument was 6.00 minutes (ranging
from 2 to 12; SD: 2.79) for the total sample, 5.69 (SD:
2.67) for euthymic, 5.29 (SD: 1.64) for depressive and
7.25 (SD: 3.26) for manic patients. No difference was
found between groups (F = 2.65; p = 0.075).
The internal consistency coefficient obtained was high,
Cronbach's alpha of 0.909, for the total scale, indicating
that the items are sufficiently homogeneous. The FAST
also showed high internal consistency on each of the
twenty-four items.
Concurrent validity based on functional impairment
according to GAF scale showed a highly significant nega-
tive correlation (r = -0.903; p < 0.001). This result indi-
cates that patients with good functioning assessed using
the FAST obtained higher scores on the GAF scale, as
shown in Figure 1. Accordingly GAF scores indicated
adjustment whereas FAST scores showed disability.
We analysed the scale's discriminant capacity between
patient and controls by means of the diagnostic perform-
ance or ROC curve. The area under the curve was 0.86,
95%CI: (0.809, 0.917) which, being close to 1, indicates
a good capacity. The discriminant capacity study indicates
that a score above 11 obtains the best balance between
sensitivity (72%) and specificity (87%). The mean total
FAST score in patients and the control group were 25.43
(0–66; SD:16.31) and the 6.07(0–20; SD: 4.72) respec-
tively.
Intra-class correlation coefficient was 0.98 (p < 0.01), as
shown in table 2. The YMRS, HDRS-17 and GAF were
assessed during test and retest to verify stability on the
A Pearson correlation between scores of GAF and scores of  FAST Figure 1
A Pearson correlation between scores of GAF and scores of 
FAST. * Negative correlation between total scores of FAST 
and GAF (r = -0.903; p < 0.001).
Table 1: Demographic and clinical variables
Bipolar 
patients
Control group
Mean SD Mean SD
Age (p value =  0.31) 45.45 13.66 49.16 17.66
Age of onset 27.82 11.84
Chronicity 17.92 11.51
Total episodes 12.35 15.06
Manic episodes 3.43 4.61
Hypomanic episodes 3.00 9.43
Depressed episodes 5.60 6.67
Hospitalization 1.93 1.96
Suicide attempts 1.44 0.49
HDRS 5.41 7.17
YMRS 4.08 6.67
GAF 63.90 19.05
n% n %
Sex (p value =  0.14)
Female 52 51.5 35 57.4
Male 49 48.5 26 42.6
Bipolar type I 89 88.3
Bipolar type II 11 10.7
Bipolar NOS 1 1Clinical Practice and Epidemiology in Mental Health 2007, 3:5 http://www.cpementalhealth.com/content/3/1/5
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mood states of patients. These results indicate that the sta-
bility of the FAST would not be altered by natural mood
variations in the patients' condition.
Validity was assessed using a discriminant measure to
detect difference between euthymic and acute patients.
The mean scores of FAST were lower in euthymic (18.55 ±
13.19; F = 35.43; p < 0.001) patients, as compared with
manic (40.44 ± 9.15) and depressed patients (43.21 ±
13.34) as shown in figure 2.
The study of the internal structure of the FAST, after rota-
tion (using Varimax method), determined a five-factor
structure, as shown in table 3. In this analysis it was
observed that the interpersonal relationship and leisure
time domains are loading on the same factor.
Discussion
High rates of functional impairment among bipolar
patients, even amongst patients whose symptoms have
remitted, have been documented in numerous studies
[4,7,22-25]. Cognitive impairment, work impairment,
household duty difficulties, interpersonal relationship
difficulties, leisure time difficulties, and sexual problems
are the main functioning problems presented by patients
[6,7,13,14,17]. However, the majority of instruments
available to date are very lengthy and have been focused
on global or limited measures of functional recovery,
rather than examining specific, discrete areas of psychoso-
cial activity [4,7]. Therefore, the development of specific
instruments to assess the functional outcome in BD is still
an unmet need [13,14]. Within this context, the FAST
could become particularly useful.
The FAST comprises twenty-four items that assess six spe-
cific areas of functioning such as autonomy, occupational
functioning, cognitive functioning, financial issues, inter-
personal relationships and leisure time. The FAST presents
advantages due to the simplicity of the instrument, the
ease of its application and the time frame required for its
implementation. In addition, the FAST shows high feasi-
bility, a quality that makes it applicable in both clinical
practice and in research settings. The instrument is also
available in three languages, a Spanish version, a Portu-
guese and an English version.
The psychometric properties of the FAST showed high
internal consistency, where the total items had a Cron-
bach's alpha above 0.9. In addition, we found a strong
concurrent validity, and discriminant validity. The test-
retest reliability, which only featured patients with stable
mood states, showed very similar results. The FAST
showed to be a sensitive instrument for the detection of
different mood states, and this was supported by the fact
that euthymic patients showed functioning results twice
as higher than depressed and manic patients. Previous
studies showed moderate to marked impairment in spe-
cific areas of functioning and the persistence of depressive
symptoms was also significantly associated with impair-
ment [3,5,12,17,24]. Strakowski et al. (2000)[7] reported
that functional recovery, and in particular, interpersonal
relationships recovery was associated with recovery from
manic symptoms. The present study showed that the
severity of symptoms was associated with higher scores of
FAST and poorer functioning.
FAST scores across different mood states in bipolar patients Figure 2
FAST scores across different mood states in bipolar patients. 
* Significant difference between euthymic patients (18.55; F = 
35.43; p < 0.001) and acute patients (manic mean: 40.44±9.15 
and depressed mean: 43.21±13.34).
Table 2: Test-Rest reliability of the FAST
Intraclass F gl p t  test F gl p
N = 15 mean SD Mean SD correlation 
FAST 37.73 16.79 34.87 16.14 0.98 40.98 14 0.0001 0.48 0.006 28 0.94
GAF 49.40 17.80 52.53 16.74 0.95 18.63 14 0.0001 -0.50 0.29 28 0.60
HDRS 10.53 10.21 9.87 9.99 0.87 7.59 14 0.0001 0.18 0.047 28 0.83
YMRS 9.80 10.10 9.00 8.44 0.93 14.23 14 0.0001 0.24 1.47 28 0.24Clinical Practice and Epidemiology in Mental Health 2007, 3:5 http://www.cpementalhealth.com/content/3/1/5
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In this study, we suggest a putative cut-off point higher
than 11, because this value improved the test's discrimi-
nant properties, obtaining a sensitivity of 72% and a spe-
cificity of 87%. Using this cut-off point, the total FAST
score was 25.43 for patients (0–66; SD: 16.31) and 6.07
for healthy controls (0–20; SD: 4.72); only five healthy
controls showed a score superior to11. These results are
consistent with previous studies, suggesting that func-
tional impairment is not restricted to acute episodes and
remitted patients may show functional impairment
despite symptomatic recovery [5-7,24,26].
As regard to concurrent validity, the FAST showed a strong
negative correlation with the GAF scale, which is the main
instrument for assessing the current level of functioning
[13,14]. The GAF gives ratings from 0 to 100, which spec-
ifies anchors for quantification of overall psychosocial
functioning adjustment, where the higher scores of GAF
represents better psychosocial functioning [12,13,27]. In
opposition to the GAF, the FAST assesses specific domains
of functioning and also identifies the level of impairment
in each area; higher scores represent higher disability thus
a negative correlation was actually expected.
Available instruments to assess functioning include the
WHO-DAS-II, SF-36, SAS and LFQ scale. WHO-DAS is an
instrument developed by The World Health Organization,
which can predict disability related outcomes. However,
the instrument is an extensive interview, which limits its
use in clinical practice and it also assesses numerous phys-
ical domains which are less relevant than mental domains
to psychiatric patients in general and bipolar patients in
particular [28]. The SF-36 is a self-reported instrument,
consisting of 36 items and 8 subscales measuring the
domains of physical and social functioning, as well as
general and emotional health [23,29]. The Social Adjust-
ment Scale (SAS) is a comprehensive instrument to assess
multiple domains of social functioning and its length is a
barrier to use in screening or routine assessment. In addi-
tion, it is most commonly used in the area of depression
treatment [30]. The Life Functioning Questionnaire (LFQ)
is a brief questionnaire which assesses duties at home, lei-
sure activities (family/friends) and duties at work [28].
However, all the scales above did not assess important
areas of functioning such as cognitive functioning and
finances. Furthermore, the use of self-reported scales to
assess functional impairment in psychiatric illness, partic-
ularly bipolar patients, is not reliable because of the exten-
sive psychopathology of these patients may make them
more prone to over-estimate or under-estimate their own
disability [5,31,32]. At this moment, the instruments
available were not developed to measure the health prob-
lems particularly associated with BD. This results in a lack
of standardisation of these instruments which gives diffi-
culties in understanding the results. In addition, the vali-
dation of the scales in other languages, in particular,
Spanish version is very important because Spanish is spo-
ken by over 352 million people worldwide [14,18,33-35].
In this context, the FAST was designed considering the
main difficulties experienced by psychiatric patients
reported in the literature and previous scales including
those expressed by bipolar patients and it is promoting a
new option to assess functional impairment in specific
domains that may be affected in bipolar patients.
Conclusion
In conclusion, the FAST showed strong psychometric
properties and it was sensitive to different mood states. In
addition, it is a simple interviewer-administered instru-
ment, which is easy to apply, only requires a short period
of time for implementation, and it is now available to be
used in the clinical practice and investigation settings. The
FAST promotes the assessment of specific domains of
functioning impairment in bipolar disorder patients.
Therefore the use of FAST may be instrumental in the
assessment of supplemental interventions targeting reha-
bilitation/functional enhancement of BD patients. FAST
may also be useful in assessing the effect of pharmacologic
and psychosocial interventions on functioning of psychi-
Table 3: Factorial loading on the FAST
F A S T *12345
EF 5 0.938
EF 9 0.908
EF 7 0.902
EF 6 0.882
EF 8 0.852
EF 17 0.741
EF 18 0.628 0.437
EF 21 0.596
EF 24 0.577 0.544
EF 23 0.552
EF 20 0.466
EF 19 0.403
EF 12
EF 13 0.746
EF 14 0.694
EF 11 0.668
EF 10 0.480
EF 4 0.741
EF 1 0.724
EF 3 0.407 0.693
EF 2 0.531
EF 22
EF 16 0.897
EF 15 0.870
* Coefficient less than 0.42 are omittedClinical Practice and Epidemiology in Mental Health 2007, 3:5 http://www.cpementalhealth.com/content/3/1/5
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atric patients, being valid, reliable and user-friendly in the
field of bipolar disorder.
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